Doping Academy

Onafhankelijk kennis- en informatiecentrum doping

Dikke dossiers?

.

De kwestie Froome past op twee A4'jes.

.

Froome en salbutamol

.

Is de Brit schuldig aan dopinggebruik? Een uitgebreide analyse.

.

Doping Academy Nieuwsbrief

.

Blijf met onze gratis Nieuwsbrief op de hoogte van de nieuwe inhoud op de Doping Academy.

.

Waarheid

.

Hoe kon Contador schuldig en onschuldig tegelijk zijn?

.

.

Lance Armstrong

.

Zeven Tourzeges: mogelijk met maar zeker niet door epo.

.

Brouwer vs Olfers I

.

Discussie over objectieve vs juridische waarheid.

.

Brouwer vs Olfers II

.

Hoe verhouden verschillende waarheden zich onderling.

.

Cancellara en mechanische doping

.

Had Spartacus echt een motortje in zijn fiets of is dat een fabel?

.

Arthur Linton

.

Een 'dopindode' uit het negentiende-eeuwse wielrennen en het WADA-antidopingbeleid.

.

Volkskrantcolumnist Bert Wagendorp noemt dit een fenomenaal boek, voor iedereen die verder wil kijken dan de simpele wedstrijd.

.

Podcast

.In een interview op NPO 1 vertelt auteur en directeur van de Doping Academy over zijn boek 'Arthur Linton. Een vermeende negentiende eeuwse dopingdode en het WADA-antidopingbeleid

.In een interview op NPO 1 vertelt auteur en directeur van de Doping Academy over zijn boek 'Arthur Linton. Een vermeende negentiende eeuwse dopingdode en het WADA-antidopingbeleid

In een interview op NPO 1 vertelt auteur en directeur van de Doping Academy over zijn boek 'Arthur Linton. Een vermeende negentiende eeuwse dopingdode en het WADA-antidopingbeleid

.

.

.

vorige
volgende
Shadow
Slider

Home | Terug


Some empirical notes on the epo epidemic in professional cycling


 

Year:   2011
Author(s):  Hein Lodewijkx and Bram Brouwer

Ref.:

(APA-norm)

 Lodewijkx, H. F. M., & Brouwer, B. (2011). Some empirical notes on the epo epidemic in professional cycling. Research Quarterly for Exercise and Sport, 82(4), 740-754.
 DOI:
10.1080/02701367.2011.10599811
Keywords:  doping, historical records of european cycling, sport performance; stage races
Language:  English
Full text:  Not free available. For publisher website see her.

 

 

Samenvatting

The 1990–2010 periods in professional cycling are labeled by some as the ‘epo epidemic.’ Surprisingly, performance enhancement of epo and blood doping is not that clear–cut for endurance athletes, leading to the question whether doping indeed strongly influenced cyclists’ performances from the 1990s onwards. We examined records (1947–2008) of the Tour de France, Giro d’Italia, and Vuelta a España (N = 181) and assessed the time it took riders to win the race. Findings revealed normally distributed performances and linear and quartic relationships in victors’ performances over time that correspond with Brewer’s (2002) socio–historical analysis of professional road racing, suggesting that effects of the epo epidemic on pro cyclists’ achievements may be overestimated.

 

References 

  • Albergotti,  R., & O’Connell, V. (2010). Blood brothers. The Wall Street Journal, 5–7–2010, 15–17.
  • Audran, M., Gareau, R., Matecki, S., Durand, F., Chenard, C., Sicart, M.-T.,. . . Bressole, F. (1999). Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Medicine and Science in Sports and Exercise, 31, 639–45.
  • Birkeland, K. I., Stray–Gundersen, J., Hemmersbach, P., Hallen J., Haug, E., & Bahr, R. (2000). Effect of rhEPO administration on serum levels in sTfR and cycling performance. Medicine and Science in Sports and Exercise, 32, 1238–1243.
  • Böning, D., Maassen, N., & Pries, A. (2008). No proof for augmented oxygen content as only factor influencing exercise capacity after EPO doping. Journal of Applied Physiology, 105, 1988–1988.
  • Brewer, B. F. (2002). Commercialization in professional cycling 1950–2001: Institutional transformations and the rationalization of “doping.” Sociology of Sport Journal, 19, 276–301.
  • Brouwer, B., Lodewijkx, H. F. M., & Kuipers, H. (2009). Doping confessions of cyclists revisited. [In Dutch: Dopingbekentenissen langs de meetlat]. Sportpsychologie Bulletin, 20, 24–37.
  • Connes, P., Perrey, S., Varray, A., Préfaut, C., & Caillaud, C. (2003). Faster oxygen uptake kinetics at the onset of submaximal cycling exercise following 4 weeks recombinant human erythropoietin(r-HuEPO) treatment. European Journal of Physiology, 447, 231–238.
  • Dimeo, P. (2007). A history of drug use in sport 1876–1976. New York: Routledge / Taylor & Francis Group.
  • Ducrot, M. (1987). Dispatches from the Tour de France. [In Dutch: Berichten uit de Tour de France]. Amsterdam: Thomas Rap.
  • Ejnès, G., Bouvet, P., Dufourq, R., Laget, S., & Schaller, G. (2002). Tour de France 100 years. (Vol. I, II, and III). [In French: Tour de France 100 ans. (Vol. I, II, and III)]. Paris: L’Equipe.
  • Ekblom, B., & Berglund, B. (1991). Effect of erythropoietin administration on maximal aerobic power. Scandinavian Journal of Medicine and Science in Sports, 1, 88–93.
  • Festinger, L. (1954). A theory of social comparison. Human Relations, 7, 117–140.
  • Field, A. (2005). Discovering statistics using SPSS (2nd ed.) London: Sage.
  • Fotheringham, W. (2009). Fallen angel: The passion of Fausto Coppi. London: Yellow Jersey Press / Random House.
  • Friedl,  K. E. (2005). Effects of testosterone and related androgens on athletic performance in men. In W. J. Kraemer & A. D. Rogol (Eds.), The endocrine system in sports and exercise (pp. 525–543). Volume XI of the encyclopaedia of sports medicine, an IOC  medical commission publication. Oxford: Blackwell Publishing.
  • Gore, C. J., Hahn, G., Burge, C. M., & Telford, R. D. (1997). VO2max and the hemoglobin mass of trained athletes during high intensity training. International Journal of Sports Medicine, 18, 477–482.
  • Gregor, R. J., Conconi, F., & Broker, J. P. (2000). Biomechanics of road cycling. In R. J. Gregor & F. Conconi (Eds.), Handbook of sports medicine and science: Road cycling (pp. 18–39). An IOC sub–commission on the sport sciences publication. Oxford: Blackwell Publishing.
  • Hoberman, J. (1992). Mortal engines: The science of performance and the dehumanization of sport. New York: The Free Press.
  • Hoberman, J. (2005). Testosterone dreams: Rejuvenation, aphrodisia, doping. Berkeley / Los Angeles: University of California Press.
  • Hopkins, W. G. (2004). How to interpret changes in an athletic performance test. Sportscience, 8, 1–7. Retrieved from the Internet, July 20, 2010, http://www.sportsci.org/jour/04/wghtests.htm.
  • Hopkins, W. G., Schabort,  E. J., & Hawley, J. A. (2001).  Reliability of power in physical performance tests. Sports Medicine, 31, 211–234.
  • Jelkmann, W. (2000). Use of recombinant human erythropoietin as an anti–anemic and performance–enhancing drug. Current Pharmaceutical Biotechnology, 1, 11–31.
  • Johnson, A. T. (2007). Biomechanics and exercise physiology: Quantitative modeling. New York: CRC Press / Taylor & Francis Group.
  • Joyner, M. J. (2003). VO2max, blood doping, and erythropoietin. British Journal of SportsMedicine, 37, 190–191.
  • Joyner, M. J., & Coyle, E. F. (2008).  Endurance exercise performance: The physiology of champions. Journal of Physiology, 586.1, 35–44.
  • Kuipers, H. (2006). Putative effects of doping in cycling. [In Dutch: Vermeende effecten van doping in de wielersport]. Nederlands Tijdschrift voor Geneeskunde, 150, 2643–2645.
  • Kuipers, H., Moran, J., Dubravcic–Simunjak, S., Mitchell, D. W., Shobe, J., Sakai, H., & Ambartsumov, R. (2007a).  Hemoglobin level in elite speed skaters from 2000 up to  2005 and its relationship with competitive results. International Journal of Sports Medicine, 28, 16–20.
  • Kuipers, H., Moran, J., Mitchell, D., Shobe, J., Dubravcic–Simunjak, S., Sakai, H., & Ambartsumov, R. (2007b). Hemoglobin levels and athletic performance in elite speed skaters during the Olympic season 2006. Clinical Journal of Sports Medicine, 17, 135–139.
  • Lasne, F. (2009). Erythropoietin doping: Detection in urine. In J. L. Fourcroy (Ed.) Pharmacology, doping and sports (pp. 107–124). London: Routledge.
  • Londres, A. (2002).  Convicts of the road. [In French: Candide chez les forçats].  In G. Ejnès, P. Bouvet,  R. Dufourq,  S. Laget, & G. Schaller (Eds.), Tour de France 100 years. (Vol. I, p. 149). [In French: Tour de France 100 ans. (Vol. I, p. 149)]. Paris: L’Equipe.
  • Lucia, A., Earnest, C., & Arribas, C. (2003). The Tour de France: a physiological review. Scandinavian Journal of Medicine and Science in Sports, 13, 275-283.
  • Lucia, A., Hoyos, J., Perez, M., Santalla A., & Chicharro, J. L. (2002). Inverse relationship between VO2max and economy/efficiency in world–class cyclists. Medicine and Science in Sports and Exercise, 34, 2079–2084.
  • Magnier, D., Picq, P., Debreilly, M., Zingoni, P., Haffreingue, H., & Bey, J.–L. (2009). Cycling remembered. [In French: Memoires du cyclisme]. Retrieved from the Internet, December 19, 2009,

    http://www.memoire–du–cyclisme.net.

  • Maso, B. (2003). We were all Gods. The Tour of 1948. [In Dutch: Wij waren allemaal goden.De Tour van 1948]. Amsterdam: Atlas.
  • Maso, B. (2005). The sweat of the Gods. Norwich (UK): Mousehold Press. Mignon, P. (2003). The Tour de France and the doping issue. International Journal of the History of Sport, 20, 227–245.
  • Miskowiak, K., Inkster, B., Selvaraj, S., Wise, R., Goodwin, G. M., & Harmer, C.J. (2008). Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmocology, 33, 611-618.
  • Nelissen, J. (1995). The bible of the Tour de France. [In Dutch: De bijbel van de Tour de France]. Maastricht (The Netherlands): WIN Publiciteit.
  • Ninot, G., Connes, P., & Caillaud, C. (2006). Effects of recombinant human erythropoietin injections on physical self in endurance athletes. Journal of Sports Sciences, 24, 383-391.
  • Noakes, T. D. (2000). Physiological models to understand exercise fatigue and the adaptations that predict or enhance athletic performance. Scandinavian Journal of Medicine and Science in Sports, 10, 123-145.
  • Robach, P., Calbet, J. A. L., Thomsen, J. J., Boushel, R., Mollard, P., Rasmussen, P., & Lundby, C. (2008). The ergogenic effect of recombinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia. PLoS ONE 3(8): e2996, doi:10.1371/journal.pone.0002996.
  • Sawka, M. N., Joyner, M. J., Miles, D. S., Roberson, R. J., Spriet, L. L., & Young, A. J. (1996).The use of blood doping as an ergogenic aid. Medicine and Science in Sports and Exercise, 28, 127–134.
  • Stray–Gundersen, J., Videman, T., & Penttilä, I. (2003). Abnormal hematologic profiles in elite cross–county skiers: Blood doping or? Clinical Journal of Sports Medicine, 13, 132–137.
  • Tabachnick, B. G., & Fidell, L. S. (2001). Using multivariate statistics. Boston: Allyn & Bacon, Tokish, J. M., Kocher, M. S.,  & Hawkins, R. J. (2004). Ergogenic aids: A review of basic science, performance, side effects, and status in sports. American Journal of Sports  Medicine, 32, 1543–1553.
  • VanIngen Schenau, G. J. (1985). Speed: A balance between exercise and friction. [In Dutch: Snelheid: Een evenwicht tussen inspanning en wrijving]. In J. P. Clarijs & G.J. van Ingen Schenau (Eds.), Cycling [In Dutch: Wielrennen] (pp. 39–67). Gent (Belgium): De Tijdstroom.
  • Varlet–Marie, E., Gaudard, E., Audran, M., & Bressolle F. (2003). Pharmacokinetics / pharmacodynamics of  recombinant human erythropoietins in doping control. Sports Medicine, 33, 301–315.
  • Verbruggen, H. (2001). The EPO epidemic in sport. Bloodline Reviews, 1, 3–4.
  • Voet, W. (2001). Breaking the chain. London: Yellow Jersey Press / Random House.
  • WADA (2010). World Anti–Doping Agency, Prohibited List. Retrieved from the Internet, July 18, 2010, http://www.wada–ama.org/en/World–Anti–Doping–Program/Sports–and–Anti–Doping–Organizations/International–Standards/Prohibited–List/.
  • Wilkerson, D. P., Rittweger, J., Berger, N. J., Naish, P. F., & Jones, A. M. (2005). Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during        exercise in humans. Journal of Physiology, 568, 639–652.

© 2007 - 2018 - Dr. Bram Brouwer, Mantgum

Link1 | Link2 | Link3

Copyright © 2007 - 2018 All Rights Reserved Bram Brouwer.